AmCad BioMed Corporation(TW:4188)
NT$13.70-0.30 (-3.86%)
TW:4188
AmCad BioMed Corporation Revenue
NT$13.70
At close:-0.30 (-3.86%)
AmCad BioMed Corporation (4188) Revenue
AmCad BioMed Corporation Revenue
AmCad BioMed Corporation had a revenue of 6.72M in the quarter ending Jun 30, 2026, with 5.18%. This bring the company's revenue in the last twelve months to 28.60M, Decreased 4.80%. In the fiscal year ending Dec 31, 2025, AmCad BioMed Corporation had annual revenue of 30.44M with -42.69% growth.
- Revenue (ttm)
- 28.60M
- Revenue Growth
- -39.87%
- P/S Ratio
- 28.51
- Revenue/Employee
- TWD 437
- Employees
- 69,576
- Market Cap
- TWD 867.66M
Revenue Chart
AmCad BioMed Corporation Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.44M | -22.67M | -42.69% |
| Dec 31, 2024 | 53.10M | -12.15M | -18.62% |
| Dec 31, 2023 | 65.26M | 3.63M | 5.88% |
| Dec 31, 2022 | 61.63M | -24.16M | -28.16% |
| Dec 31, 2021 | 85.79M | 21.85M | 34.17% |
| Dec 31, 2020 | 63.94M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.